Longevity Medical Institute FAQ's

Yes, our therapies are approved by COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios), the Mexican equivalent of the FDA. COFEPRIS ensures the safety, efficacy, and quality of medical treatments in Mexico. Our clinic is fully licensed for Regenerative Medicine Applications, adhering to COFEPRIS’s rigorous safety and quality standards. Are These Therapies Approved in Mexico? The therapies we offer should be considered investigational and experimental according to FDA regulations. Individual outcomes may vary, and there are associated risks with any medical treatment. We strongly encourage patients to consult with their healthcare providers in their home country to understand the potential benefits and risks fully. What Should I Know About These Therapies? LMI operates under the strict oversight of COFEPRIS, ensuring compliance with all regulatory standards in Mexico. Additionally, our expert physicians are available to discuss our protocols, patient safety measures, and the scientific basis of our therapies, providing transparency and confidence in the care we deliver. How Does LMI Ensure Patient Safety? We are committed to providing the highest level of care by adhering to all relevant regulations in Mexico, integrating the latest scientific research, and prioritizing patient safety. Our mission is to offer transparent, effective, and ethical therapies tailored to your needs. What Steps Does LMI Take to Maintain High Standards of Care?

Are These Therapies Available in Other Countries?

The availability of these therapies may vary depending on the regulatory guidelines of each country. While they are approved by COFEPRIS in Mexico, they may not yet be approved in the United States or other countries with similar regulatory frameworks. Patients should consider these therapies investigational and consult with local healthcare providers for guidance.

Longevity Medical Institute (C) Copyright. All Rights Reserved.

07 58

Made with FlippingBook flipbook maker